Picture of Bionote logo

377740 Bionote Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSuper Stock

Annual cashflow statement for Bionote, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUSAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line528,229671,556307,798-20,49755,261
Depreciation
Amortisation
Non-Cash Items31,361-169,6078,79925,284-30,003
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-321,55131,336-73,948-17,18724,472
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities239,926537,392249,100-4,19457,917
Capital Expenditures-26,722-51,544-42,484-4,542-10,482
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-84,671-139,83911,953-477,013-71,688
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-111,393-191,383-30,530-481,555-82,170
Financing Cash Flow Items415-50,37950-39.50
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-11,665-50,59622,955-49,901-24,663
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash116,504295,532262,455-533,672-40,054